ReviewMaterials (Basel, Switzerland)2025
MXenes: Manufacturing, Properties, and Tribological Insights.
Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Synthesis and Surface Engineering of Two-Dimensional MXenes for Advanced Functional Applications.Chemical record (New York, N.Y.) · 2026Review
- Editor's Choice Articles in the Manufacturing Processes and Systems Section: Emerging Directions in Advanced Manufacturing.Materials (Basel, Switzerland) · 2026Article
- Special Issue "Advances in Friction, Wear-Resistant and Solid-Lubricating Properties of Materials".Materials (Basel, Switzerland) · 2026Article
- A mechanically compliant MnORSC advances · 2026Article
- Nanocellulose Materials: Processing, Properties, and Application.Nanomaterials (Basel, Switzerland) · 2026Review
- Advances in MXene Materials: Fabrication, Properties, and Applications.Materials (Basel, Switzerland) · 2025Review
- Tribology of MXene Materials: Advances, Challenges, and Future Directions.Materials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MXenes, a novel class of two-dimensional (2D) transition metal carbides and nitrides, have garnered significant attention due to their exceptional thermal conductivity, electrical properties, and mechanical strength. This review offers a comprehensive overview of MXenes, focusing on their synthesis methods, material properties, tribological performance, and potential challenges and opportunities. Typically synthesized through the selective etching of layered precursors, MXenes offer highly tunable structures, allowing for precise tailoring for specific functionalities. Their outstanding properties, such as high electrical conductivity, chemical versatility, mechanical durability, and intrinsic lubricity, make them promising candidates for various applications, including energy storage, electromagnetic shielding, water purification, biosensing, biomedicine, and advanced tribological systems. While many of these applications are briefly acknowledged, this review primarily emphasizes MXenes' potential in tribological applications, where recent studies have highlighted their promise as solid lubricants and tribological additives due to their low shear strength, layered structure, and ability to form protective tribofilms under sliding contact. However, challenges such as oxidation resistance, long-term stability, and performance under extreme environments continue to impede their full potential. With less than a decade of focused research, the field is still evolving, but MXenes hold tremendous promise for revolutionizing modern material science, especially in next-generation lubrication and wear-resistant systems. This review explores both the opportunities and challenges associated with MXenes, emphasizing their emerging role in tribology alongside their broader engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.